Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser to market
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development
Protein analytics provides a deep insight into these complex macromolecules, their structure, function and interactions. It is essential for discovering and developing biopharmaceuticals, understanding disease mechanisms, and identifying therapeutic targets. Techniques such as mass spectrometry, Western blot and immunoassays allow researchers to characterize proteins at the molecular level, determine their concentration and identify possible modifications.
© 1997-2024 LUMITOS AG, All rights reserved